EN DE

BDH Industries Limited (524828) Fair Value & Analysis

Other · IN · Market cap ₹430M

BI BDH Industries Limited 524828 · BSE
Price₹513.80
Fair Value₹250.78
Upside-51.2%
Quality67/100
Watch BDH Industries Limited for free, get notified when fair value or trend changes. Watch for free
Expensive Growth
Solidly profitable · 10.8% net margin
Low debt · negative free cash flow
3.23% dividend yield
Ranks above peers (10/13)
Moderate moat 55/100
Evidence: High Range ₹174.40 – ₹370.08 Share as image

Fair value as of: Jul 4, 2026

From 17 valuation models · updated 36 days ago

Share price +44.1% over the past month.

A solid business, but screening 51% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (₹370.08). The favourable scenario is already priced in.
  • Solid but not exceptional quality (67/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range (₹174.40 to ₹370.08) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

₹514.10 ₹75.64 Fair Value ₹250.78 Mar 2021 Jul 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 4, 2026.

How to read this chart

60‑month range ₹75.64 – ₹514.10 · fair‑value band ₹174.40 – ₹370.08 · the ₹513.80 price screens above the ₹250.78 fair value. Dashed = 300-day average. As of Jul 4, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

BDH Industries Limited (524828) currently trades at ₹513.80, while our model-based Fair Value estimate is ₹250.78, implying the stock looks roughly 51.2% overvalued today. The Quality Score stands at 67/100 (solid quality), in the Other sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).

Over the trailing twelve months, BDH Industries Limited generated revenue of ₹522M at a net margin of 10.8%. Revenue grew 18.5% year over year. It earns a return on equity of 14.8%. The stock trades on a trailing P/E of 7.8. Fundamentals as of Jul 4, 2026

Our scenario range runs from ₹174.40 (bear case) to ₹370.08 (bull case); at ₹513.80, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 3% below its 52-week high and 103% above its 52-week low. For context, the median of 10 Other peers we cover trades at -22% fair-value upside, at -51%, 524828 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model BearBaseBull Evidence
Highest evidence
Residual Income ₹116.12 ₹144.49 ₹329.88 76
ROIC Compounder ₹228.59 ₹270.24 ₹318.11 72
Gordon GGM ₹34.96 ₹63.00 ₹86.73 70
All 17 models by family
DCF Models
Owner Earnings ₹275.20 ₹413.34 ₹622.77 31
Earnings-Based
Graham-Dodd ₹127.72 ₹579.24 ₹794.46 54
Lynch FV ₹151.46 ₹216.38 ₹281.29 50
PEG = 1.0 ₹151.46 ₹216.38 ₹281.29 46
EPV ₹213.28 ₹233.81 ₹250.91 59
Dividend Discount
Gordon GGM ₹34.96 ₹63.00 ₹86.73 70
DDM Multi-Stage ₹34.96 ₹57.55 ₹67.30 61
Multiples
P/E Multiple ₹239.48 ₹319.31 ₹399.13 63
P/S Multiple ₹187.50 ₹250.00 ₹312.50 58
P/B Multiple ₹239.48 ₹319.31 ₹399.13 55
EV/EBIT ₹300.04 ₹379.13 ₹458.23 53
EV/EBITDA ₹243.53 ₹303.79 ₹364.05 54
EV/Revenue ₹237.75 ₹312.75 ₹387.75 43
Asset-Based
NCAV (Graham) ₹61.33 ₹82.18 ₹122.66 50
Economic Profit
Residual Income ₹116.12 ₹144.49 ₹329.88 76
ROIC Compounder ₹228.59 ₹270.24 ₹318.11 72
Growth Earnings
Growth-Adj P/E ₹219.06 ₹312.94 ₹406.82 68

Widest divergence: DCF Models (₹413.34) versus Dividend Discount (₹57.55). Highest evidence: Residual Income (76).

Key figures & financial health

Revenue (TTM) ₹522M
Revenue growth (YoY) +18.5%
Net margin 10.8%
Return on equity 14.8%
Free cash flow −₹24.4M FY2026
P/E ratio 7.8
More key figures
Operating margin 13.7%
EPS (TTM) ₹9.80
Dividend yield 3.2%
EPS growth (YoY) +45.7%

Figures from reported company fundamentals · as of Jul 4, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 67/100

Of which business quality 64 · Market factors (momentum, volatility) 77

Profitability 64
Margins and returns on capital today
Quality Growth 66
Are margins and returns improving?
Cashflow 8
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 48
Calm price path (market factor)
Momentum 84
Price trend over the last 3–12 months (market factor)
52W Momentum 98
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

BDH Industries Limited manufactures and sells therapeutic formulations covering a range of pharmaceuticals in India. It offers analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, …

Full company description

BDH Industries Limited manufactures and sells therapeutic formulations covering a range of pharmaceuticals in India. It offers analgesic/antipyretic, analgesic balm, antacids, acaricide, anthelmintics, antiprotozoal, aniti-glaucoma, antiseptics, anti-psychotics, anti-tuberculosis, anti-allergics, anti-tussive, antiasthamatics, antibacterial, antiseptic, anticancer, anticoagulants, anticonvulsants, antidiabetics, anti-emetics, antifungal, antigout, antimalaraial, antiparkinsonisms, antispasmodics, and antiulcer pharmaceutical products. The company also provides antivirals, sedatives/anxiolytics/antidepressants, calcium supplements, cardiovascular products, carminatives/aromatics, corticosteroids, diuretics, drugs acting on uterus, electrolyte replinishers, expextorants, iron supplements, laxatives, local anesthetics, general anesthetics, mydriatics, narcotic-analgesics, non-steroidal anti-inflammatory products, rubefacient and mild analgesics, and pharmaceutical aid products. In addition, it offers skin protectives, skin smootheners, and vitamins, as well as SOULFIL, an oral pill for the treatment of erectile dysfunction in men. The company exports its products to the United States, Canada, Latin America, the Caribbean Islands, Europe, Russia, Gulf Countries, Australia, African countries, Asia, and Far East countries. BDH Industries Limited was founded in 1935 and is based in Mumbai, India.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

BDH Industries Limited reported revenue of ₹960M in FY2026 versus ₹694M in FY2022, a compound +8.4%/yr. Reported net income was ₹108M in FY2026, compounding +10.6%/yr from FY2022.

Growth Quality 61/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2026)
₹960M
Latest YoY
+44.3%
Avg. growth/yr (3Y)
+8.8%
Avg. growth/yr (5Y)
+10.8%
Avg. growth/yr (12Y)
+7.0%
Revenue +8.4%/yr
FY22 ₹694M
FY23 ₹745M
FY24 ₹858M
FY25 ₹665M
FY26 ₹960M
Net income +10.6%/yr
FY22 ₹72.2M
FY23 ₹82.0M
FY24 ₹98.7M
FY25 ₹92.7M
FY26 ₹108M

524828 screens 51% overvalued. Compare with Federal Home Loan Mortgage Corporation →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "BDH Industries Limited Fair Value". https://www.fairvalue-calculator.com/stock/524828

Peer Group

Other · 390 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 67 · Top 25%
Fair Value upside −51% · Below median
Return on equity (TTM) 15% · Top 25%
Return on assets 7% · Top 25%
Net margin (TTM) 11% · Top 25%
Operating margin (TTM) 14% · Top 25%
Revenue growth 19% · Top 25%
Dividend yield (TTM) 3.2% · Top 25%

Valuation Multiples vs Other median · lower = cheaper

P/E (TTM) 7.8× · Cheaper than median
P/B 0.61× · Pricier than median
P/S (TTM) 0.82× · Pricier than median
EV/EBITDA 0.9× · Cheaper than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 8
FUTURE 93 · sector 0
PAST 59 · sector 0
HEALTH 100 · sector 97
DIVIDEND 65 · sector 0

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Other stocks, each showing price versus our Fair Value estimate (as of Jul 4, 2026).

Stock Price Fair Value vs Fair Value
Federal Home Loan Mortgage Corporation FREJO $15.84 $52.77 +233%
533278 533278 ₹438.60 ₹720.31 +64%
Nestl?? India Limited 500790 ₹1,459 ₹191.93 -87%
540376 540376 ₹3,993 ₹1,806 -55%
540777 540777 ₹567.55 ₹142.69 -75%
Lupin Limited 500257 ₹2,476 ₹1,983 -20%
540719 540719 ₹1,788 ₹850.02 -52%
524804 524804 ₹1,620 ₹1,268 -22%
540716 540716 ₹1,612 ₹1,224 -24%
Eicher Motors Limited 505200 ₹7,340 ₹6,859 -7%

Compare BDH Industries Limited with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is BDH Industries Limited (524828) overvalued or undervalued?
As of Jul 4, 2026, our model estimates a fair value of ₹250.78 versus a price of ₹513.80, about −51% (overvalued).
What is the fair value of 524828?
Our model-based fair value for BDH Industries Limited is ₹250.78 (as of Jul 4, 2026), built from audited fundamentals. The current price is ₹513.80.
What is the quality score of 524828?
BDH Industries Limited has a Quality Score of 67/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of BDH Industries Limited (524828)?
BDH Industries Limited reported trailing-twelve-month revenue of about ₹522M (latest available figure, as of Jul 4, 2026).
What is the net profit margin of 524828?
The net profit margin of BDH Industries Limited is about 10.8%, meaning it keeps roughly 10.8% of revenue as net income. Based on the latest reported figures.
Does BDH Industries Limited pay a dividend?
BDH Industries Limited currently shows a dividend yield of about 3.23% relative to its recent price (as of Jul 4, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track BDH Industries Limited and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.